Phreesia (NYSE:PHR) Insider Evan Roberts Sells 6,317 Shares

Phreesia, Inc. (NYSE:PHR) insider Evan Roberts sold 6,317 shares of Phreesia stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.01, for a total transaction of $107,452.17. Following the completion of the sale, the insider directly owned 834,632 shares of the company’s stock, valued at approximately $14,197,090.32. The trade was a 0.75% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Evan Roberts also recently made the following trade(s):

• On Friday, October 17th, Evan Roberts sold 1,888 shares of Phreesia stock. The shares were sold at an average price of $22.36, for a total value of $42,215.68.

Phreesia Stock Down 0.6%

Shares of NYSE:PHR traded down $0.10 on Monday, reaching $17.14. The company had a trading volume of 760,277 shares, compared to its average volume of 1,018,096. The stock has a market capitalization of $1.03 billion, a P/E ratio of -171.33 and a beta of 0.61. The stock has a 50-day moving average price of $18.95 and a 200 day moving average price of $23.69. Phreesia, Inc. has a twelve month low of $15.41 and a twelve month high of $32.76. The company has a quick ratio of 2.44, a current ratio of 2.44 and a debt-to-equity ratio of 0.01.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 8th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.11. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The business had revenue of $120.33 million for the quarter, compared to analyst estimates of $119.98 million. During the same quarter in the prior year, the firm posted ($0.25) EPS. The firm’s revenue for the quarter was up 12.7% on a year-over-year basis. On average, equities analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on PHR. Royal Bank Of Canada began coverage on shares of Phreesia in a research note on Friday. They issued an “outperform” rating and a $26.00 price objective for the company. Zacks Research lowered Phreesia from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 6th. Robert W. Baird decreased their target price on Phreesia from $31.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, December 10th. Canaccord Genuity Group lowered their target price on Phreesia from $38.00 to $33.00 and set a “buy” rating on the stock in a report on Tuesday, December 9th. Finally, Mizuho dropped their price target on Phreesia from $36.00 to $28.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 10th. Seventeen analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Phreesia currently has an average rating of “Moderate Buy” and an average price target of $30.06.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently made changes to their positions in PHR. Federated Hermes Inc. bought a new stake in Phreesia in the third quarter valued at about $32,000. Asset Management One Co. Ltd. acquired a new stake in Phreesia during the third quarter valued at approximately $45,000. State of Alaska Department of Revenue bought a new stake in shares of Phreesia in the 3rd quarter valued at approximately $83,000. Farther Finance Advisors LLC grew its stake in shares of Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after purchasing an additional 3,000 shares during the period. Finally, Anchor Investment Management LLC acquired a new position in shares of Phreesia in the 3rd quarter worth approximately $118,000. 92.10% of the stock is owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.